Source: Annual Congress 2006 - Recent advances in the treatment of asthma and allergic rhinitis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. F. Rabe, T. Atienza, P. Magyar, P. Larsson, C. Jorup, U. G. Lalloo (Leiden, Netherlands; Quezon City, Philippines; Budapest, Hungary; Lund, Sweden; Durban, South Africa). A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma. Eur Respir J 2006; 28: Suppl. 50, 3866

Member's Comments

No comment yet.

Related content which might interest you: Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 What is the role of oral corticosteroids in the era of biologics in asthma? Source: International Congress 2019 – State of the art session: Airway disease Year: 2019 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective Source: Eur Respir J 2005; 26: Suppl. 49, 277s Year: 2005 Is there a problem with oral corticosteroid use in asthma? Source: Virtual Congress 2020 – Airway diseases Year: 2020 How effective are oral steroids in asthma action plans? Source: International Congress 2017 – Asthma management Year: 2017 The development of an algorithm for the rational use of intravenous salbutamol in severe paediatric asthma Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008 Single inhaler therapy with budesonide/formoterol in an allergic rat model: a new therapeutic strategy in asthma Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids Year: 2004 Proof of concept study to evaluate step down therapy with inhaled corticosteroid alone or additive therapy on surrogate inflammatory markers in asthma Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Pharmacological characterization of CHF6162, a novel long acting inhaled corticosteroid for the treatment of asthma Source: International Congress 2017 – Novel mechanisms and treatments for asthma Year: 2017 Budesonide/formoterol for maintenance and as needed — a new approach to asthma management in children Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005 The concept study: comparative influence of two treatment strategies on airway response to AMP Source: Annual Congress 2005 - Combination therapy for asthma. Which, why and how? Year: 2005 High or standard initial dose of budesonide to control mild-to-moderate asthma? Source: Eur Respir J 2001; 17: 856-862 Year: 2001 The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Emerging biologic approaches for the treatment of difficult to control asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice? Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019 Year: 2019 Once per day inhaled corticosteroids: a method to improve compliance and asthma control Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001 Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010 First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007